Ketamine and Suicidal Ideation: Direct Effect or Epiphenomenon?

Glue, Paul; Menkes, David

dc.contributor.author	Glue, Paul	en
dc.contributor.author	Menkes, David	en
dc.date.accessioned	2017-05-14T23:19:02Z	en
dc.date.issued	2017-04	en
dc.identifier.citation	Journal of Clinical Psychopharmacology 37(2):282-283 Apr 2017	en
dc.identifier.issn	0271-0749	en
dc.identifier.uri	http://hdl.handle.net/2292/32889	en
dc.format.medium	Print-Electronic	en
dc.language	eng	en
dc.publisher	Lippincott Williams & Wilkins Ltd.	en
dc.relation.ispartofseries	Journal of Clinical Psychopharmacology	en
dc.rights	Items in ResearchSpace are protected by copyright, with all rights reserved, unless otherwise indicated. Previously published items are made available in accordance with the copyright policy of the publisher.	en
dc.rights.uri	https://researchspace.auckland.ac.nz/docs/uoa-docs/rights.htm	en
dc.title	Ketamine and Suicidal Ideation: Direct Effect or Epiphenomenon?	en
dc.type	Journal Article	en
dc.identifier.doi	10.1097/jcp.0000000000000646	en
pubs.issue	2	en
pubs.begin-page	282	en
pubs.volume	37	en
dc.rights.holder	Copyright: Wolters Kluwer Health, Inc.	en
dc.identifier.pmid	28099185	en
pubs.end-page	283	en
dc.rights.accessrights	http://purl.org/eprint/accessRights/RestrictedAccess	en
pubs.subtype	Letter	en
pubs.elements-id	609112	en
pubs.org-id	Medical and Health Sciences	en
pubs.org-id	School of Medicine	en
pubs.org-id	Psychological Medicine Dept	en
dc.identifier.eissn	1533-712X	en
pubs.record-created-at-source-date	2017-05-15	en
pubs.dimensions-id	28099185	en